These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9242528)

  • 1. Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation. Italian Cooperative Group for Phlebotomy Treatment of Transplanted Thalassemia Patients.
    Angelucci E; Muretto P; Lucarelli G; Ripalti M; Baronciani D; Erer B; Galimberti M; Giardini C; Gaziev D; Polchi P
    Blood; 1997 Aug; 90(3):994-8. PubMed ID: 9242528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of iron overload in the "ex-thalassemic". Report from the phlebotomy program.
    Angelucci E; Muretto P; Lucarelli G; Ripalti M; Baronciani D; Erer B; Galimberti M; Annibali M; Giardini C; Gaziev D; Rapa S; Polchi P
    Ann N Y Acad Sci; 1998 Jun; 850():288-93. PubMed ID: 9668550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron burden and liver fibrosis decrease during a long-term phlebotomy program and iron chelating treatment after bone marrow transplantation.
    Meo A; Ruggeri A; La Rosa MA; Zanghì L; Morabito N; Duca L
    Hemoglobin; 2006; 30(1):131-7. PubMed ID: 16540426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversibility of cirrhosis in patients cured of thalassemia by bone marrow transplantation.
    Muretto P; Angelucci E; Lucarelli G
    Ann Intern Med; 2002 May; 136(9):667-72. PubMed ID: 11992302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-year results from a prospective randomized trial comparing phlebotomy with deferasirox for the treatment of iron overload in pediatric patients with thalassemia major following curative stem cell transplantation.
    Inati A; Kahale M; Sbeiti N; Cappellini MD; Taher AT; Koussa S; Nasr TA; Musallam KM; Abbas HA; Porter JB
    Pediatr Blood Cancer; 2017 Jan; 64(1):188-196. PubMed ID: 27576370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation from a deceased donor with β-thalassemia intermedia is not contraindicated: A case report.
    Gumus E; Abbasoglu O; Tanyel C; Gumruk F; Ozen H; Yuce A
    Pediatr Transplant; 2017 May; 21(3):. PubMed ID: 28211259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
    Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
    Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial serum ferritin predicts number of therapeutic phlebotomies to iron depletion in secondary iron overload.
    Panch SR; Yau YY; West K; Diggs K; Sweigart T; Leitman SF
    Transfusion; 2015 Mar; 55(3):611-22. PubMed ID: 25209879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early iron reduction programme for thalassaemia patients after bone marrow transplantation.
    Li CK; Lai DH; Shing MM; Chik KW; Lee V; Yuen PM
    Bone Marrow Transplant; 2000 Mar; 25(6):653-6. PubMed ID: 10734300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of iron overload management in allogeneic hematopoietic cell transplantation survivors.
    Majhail NS; Lazarus HM; Burns LJ
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):832-7. PubMed ID: 20079863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.
    Daar S; Pathare AV
    Ann Hematol; 2006 May; 85(5):315-9. PubMed ID: 16450126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron removal in ex-thalassemics after BMT: preliminary results from the phlebotomy program. Italian Cooperative Group for Phlebotomy in Ex-thalassemic.
    Angelucci E; Baronciani D; Giardini C; Argiolu F; Becchelli G; Borgna Pignatti C; Campisi S; Careddu F; Conter V; De Nunzio A
    Bone Marrow Transplant; 1993; 12 Suppl 1():105. PubMed ID: 8374546
    [No Abstract]   [Full Text] [Related]  

  • 13. A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis.
    Cazzola M; Borgna-Pignatti C; Locatelli F; Ponchio L; Beguin Y; De Stefano P
    Transfusion; 1997 Feb; 37(2):135-40. PubMed ID: 9051086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
    Gaziev J; Sodani P; Polchi P; Andreani M; Lucarelli G
    Ann N Y Acad Sci; 2005; 1054():196-205. PubMed ID: 16339666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
    Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desferrioxamine therapy accelerates clearance of iron deposits after bone marrow transplantation for thalassaemia.
    Giardini C; Galimberti M; Lucarelli G; Polchi P; Angelucci E; Baronciani D; Gaziev D; Erer B; La Nasa G; Barbanti I
    Br J Haematol; 1995 Apr; 89(4):868-73. PubMed ID: 7772524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Kamble RT; Selby GB; Mims M; Kharfan-Dabaja MA; Ozer H; George JN
    Biol Blood Marrow Transplant; 2006 May; 12(5):506-10. PubMed ID: 16635785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of deferiprone on liver iron overload and fibrosis in hepatitis-C-virus-infected thalassemia.
    Chen AC; Peng CT; Wu SF; Wu KH; Chiang IP; Tsai CH
    Hemoglobin; 2006; 30(2):209-14. PubMed ID: 16798645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between soluble transferrin receptor and serum ferritin levels following bone marrow transplantation for thalassemia.
    Centis F; Delfini C; Agostinelli F; Barbanti I; Annibali M; Lucarelli G
    Eur J Haematol; 1995 May; 54(5):329-33. PubMed ID: 7781757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous chelation therapy during transplantation for thalassemia.
    Gaziev D; Giardini C; Angelucci E; Polchi P; Galimberti M; Baronciani D; Erer B; Maiello A; Lucarelli G
    Haematologica; 1995; 80(4):300-4. PubMed ID: 7590497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.